*To be consumed as directed by physician.
Therapies:
Biotech Product
Composition:
Trastuzumab 440Mg
Herti 440Mg Injection consists of Trastuzumab as an active constituent which is indicated for its use in HER 2-breast cancer. In HER 2 positive patients, the breast cancer cells are mostly composed of HER2 proteins that cause rapid development of cancer tumor by serving as a signal to the cancerous. This medication is also used to treat metastatic gastric cancer with increased levels of HER2 proteins.
Her 2 positive breast cancer are most aggressive in nature. The targeted therapy for her 2 positive breast cancer works by selectively targeting the proteins that are responsible for the growth, development, and spread of cancer.
*To be consumed as directed by physician.
Herti 440Mg Injection is indicated for its use in the following conditions:
